OTC grows 4% at Pfizer thanks to Nexium

4 February 2016 - Deborah Wilkes

Worldwide sales by Pfizer's Consumer Healthcare business increased by 4% on an operational basis in the fourth quarter of 2015 "primarily due to Nexium 24HR in the US".